{
    "relation": [
        [
            "Feature key",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi",
            "Describes the effect of the experimental mutation of one or more amino acid(s) on the biological properties of the protein.More...Mutagenesisi"
        ],
        [
            "Position(s)",
            "6 \u2013 6",
            "9 \u2013 11",
            "11 \u2013 11",
            "51 \u2013 51",
            "55 \u2013 55",
            "55 \u2013 55",
            "60 \u2013 60"
        ],
        [
            "Length",
            "1",
            "3",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "Y \u2192 F: Decrease in potency of about 10-fold, without affecting the selectivity for Nav1.4, Nav1.6 and Nav1.7. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "DDK \u2192 KPH: Increase in potency for Nav1.4 (1.6-fold) and Nav1.7 (2.3-fold) and decrease in potency for Nav1.6 (fold), resulting in a 40-fold increase of selectivity for Nav1.7 over Nav1.6. No change in potency for Nav1.4 and Nav1.6, and important increase in potency for Nav1.7 (11.7-fold); when associated with A-55. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "K \u2192 V: Increase in potency for Nav1.4 (5-fold) and Nav1.6 (7.8-fold) and decrease in potency for Nav1.7 (4.3-fold), resulting in a 5-fold increase of selectivity for Nav1.6 over Nav1.7. Increase in potency for Nav1.6 (16-fold), no change in potency for Nav1.7, and decrease in potency for Nav1.4 (1.6-fold); when associated with A-55. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "K \u2192 A: No change in potency for Nav1.4, Nav1.6 and Nav1.7. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "E \u2192 A: No change in potency for Nav1.4 and Nav1.7, and important decrease in potency for Nav1.6 (2.3-fold), resulting in a 13-fold increase of selectivity for Nav1.4 and Nav1.7 over Nav1.6. No change in potency for Nav1.4; Nav1.6, and important increase in potency for Nav1.7 (11.7-fold); when associated with 9-K--H-11. Increase in potency for Nav1.6 (16-fold), no change in potency for Nav1.7, and decrease in potency for Nav1.4 (1.6-fold); when associated with V-11. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "E \u2192 H: No change in potency for Nav1.4 and Nav1.7, and decrease in potency for Nav1.6 (1.7-fold). 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60.",
            "I \u2192 G: No change in potency for Nav1.4, and decrease in potency for Nav1.6 (1.6-fold) and Nav1.7 (2.6-fold). 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T., Vetter I., Wang C.I., Motin L., Knapp O., Adams D.J., Lewis R.J., Alewood P.F. ACS Chem. Biol. 8:1215-1222(2013) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), SYNTHESIS, FUNCTION, TOXIN TARGET, DISULFIDE BONDS, MUTAGENESIS OF TYR-6; 9-ASP--LYS-11; LYS-11; LYS-51; GLU-55 AND ILE-60."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "Alpha-toxin OD1 - Odontobuthus doriae (Yellow Iranian scorpion)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P84646",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 2,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042982502.13/warc/CC-MAIN-20150728002302-00091-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 781050271,
    "recordOffset": 781023376,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 26 Nov 2014 00:00:00 GMT",
    "textBeforeTable": "Mutagenesis <p>Provides information on the disease(s) and phenotype(s) associated with the deficiency of a protein.</p><p><a href='../manual/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechi Secreted <p>UniProtKB Keywords constitute a <a target=\"_top\" href=\"/keywords\">controlled vocabulary</a> with a hierarchical structure. Keywords summarise the content of a UniProtKB entry and facilitate the search for proteins of interest.<p><a href='/help/keywords' target='_top'>More...</a></p>Keywords - Cellular componenti Complete GO annotation... 16038905 <p>Inferred from Direct Assay</p> <p>Used to indicate a direct assay for the function, process or component indicated by the GO term.</p> <p>More information in the <a href=\"http://geneontology.org/page/guide-go-evidence-codes#ida\">GO evidence code guide</a></p> Inferred from direct assayi extracellular region Source: UniProtKB <p>The <a href=\"http://www.geneontology.org/\">Gene Ontology (GO)</a> project provides a set of hierarchical controlled vocabulary split into 3 categories:</p><p><a href='../manual/gene_ontology' target='_top'>More...</a></p>GO - Cellular componenti PROTEIN SEQUENCE, FUNCTION, TOXIN TARGET, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY, AMIDATION AT ARG-65. Cited for: Abstract] Europe PMC] [ PubMed] [ FEBS Lett. 579:4181-4186(2005) [ Tytgat J. Vatanpour H., Schoofs L., Sarbolouki M.N., Zaremirakabadi A., Cuypers E., Clynen E.,",
    "textAfterTable": "<p>Describes post-translational modifications (PTMs) and/or processing events.</p><p><a href='../manual/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingi Molecule processing Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the extent of a polypeptide chain in the mature protein following processing.</p><p><a href='../manual/chain' target='_top'>More...</a></p>Chaini 1\u00a0\u2013\u00a065 65 Alpha-toxin OD1 PRO_0000066788 Add BLAST Amino acid modifications Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the positions of cysteine residues participating in disulfide bonds.</p><p><a href='../manual/disulfid' target='_top'>More...</a></p>Disulfide bondi 13 \u2194 64 1 Publication <p>Manually curated information for which there is published experimental evidence.</p> <p><a href=\"/manual/evidences#ECO:0000269\">More\u2026</a></p> Manual assertion based on experiment ini Ref.3 \"Chemical Engineering and Structural and Pharmacological Characterization of the alpha-Scorpion Toxin OD1.\" Durek T.,",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}